Ensuring A Zero-Risk Data Privacy Environment When Capturing Medical Insights

Partner Content
Pharmapforum Grapic zero risk data

Capturing Medical Insights With Zero-Risk

When capturing medical and field insights you have to comply with numerous regulations relevant to the world of data privacy – a challenge often compounded by the many different variables that govern the process of insight capture and analysis.

Some of these include:

What is the source of the insight? Whether your insights are captured from a pre-planned Advisory Board, or an impromptu discussion between an MSL and a KOL at a Congress, can impact how you treat both the insight and the details about the HCP(s) from where the insights were gained.

What is the MSL location? Countries, regions, and even states, have their own data privacy requirements which can apply to the how you capture an insight generated from medical affairs and field medicine activities and interactions.

What is the KOL location? Consider the following (especially European) scenario where an MSL or Medical Affairs professional may, as part of their normal working day, interact and speak to different KOLs in different countries. And each country may have a different data privacy journey in the context of insights collected from those KOLs present in that country.

What was the context of capture? For example, did the insight you want to capture into your insights platform come from an observation of a Q&A session after a KOL podium presentation, or did the insight come from a pre-planned 1-to-1 interaction with a KOL?

What is your corporate compliance policy? It’s not uncommon to find that two pharma companies of similar size and scope, headquartered in the same country, will have different interpretations of legal and regulatory facets. For example, one may freely allow the capture of the name of the KOL associated with an insight, and the other may deem this an absolute no-go under any circumstances.

The above are just some of the issues which must be taken into consideration when designing a zero-risk system to enable the capture of medical affairs insights from KOL activities, interactions, and observations.

Relying on human input alone to ensure adherence to all such needs at the point-of-capture is pretty much impossible, and the only realistic way to deal with all of this is to ensure your technology solution to capture and manage your medical insights is able to account for all scenarios – automatically and instantly.

In fact, ideally such privacy and compliance controls should be baked into the platform right from the very start. This can allow each team (and even each user, if needed) to have their own dynamic workflow that considers all variables – country, national regulations, state/local regulations, KOL location, organisational requirements, and more – at the point of capture to automatically guide the user through a compliant process, regardless of situation. All towards the goal of “zero-risk”!

Robert Hollands

Business Development Account Manager

KOL Insights at VMLY&R Health

e: robert.hollands@vmlyr.com

t :+44 (0)20 3443 8914

w: https://vmlyr-digitalsolutions.com/X-fly-Insights.html

a: Rose Court, 2 Southwark Bridge Road, London, SE1 9HS


VMLY&R Health

VMLY&R Health

13 December, 2022